|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of goods sold ("COGS") | ||||
| Gross margin | ||||
| Selling, general and administrative expenses ("SG&A") | ||||
| Foreign exchange ("FX") loss | ||||
| Operating income | ||||
| Gain on disposal of PP&E | ||||
| Loss on financial instruments | ||||
| Derecognition and unrealized (loss) gain on redemption options | ||||
| Equity earnings from associates and joint ventures | ||||
| Impairment of goodwill | ||||
| Earnings (loss) before finance costs and income taxes | ||||
| Earnings before finance costs and income taxes ("EBIT") | ||||
| Net finance costs | ||||
| Earnings (loss) before income taxes ("EBT") | ||||
| Current income taxes | ||||
| Deferred income taxes | ||||
| Income taxes | ||||
| Net earnings (loss) | ||||
| Other comprehensive income (loss) | ||||
| Items that may be reclassified to profit or loss in subsequent periods | ||||
| Change in fair value of derivatives designated as cash-flow hedges, net of income tax recovery | ||||
| Gain on derivatives designated as cash flow hedges transferred to net earnings (loss), net of income tax expense | ||||
| Unrealized gain (loss) on translation of foreign-denominated debt | ||||
| Unrealized gain (loss) on translation of financial statements of foreign operations | ||||
| Other comprehensive income (loss) | ||||
| Total comprehensive income (loss) | ||||
| Earnings (loss) per share - basic | ||||
| Earnings (loss) per share - diluted | ||||
| Weighted average number of shares – basic | ||||
| Weighted average number of shares – diluted |
Loading...
